Key facts
- It has raised $23.9M.
- Notable investors include Korea Development Bank, IMM Investment, Enlight Ventures, Premier Partners, BNK Venture Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Absology
- ·The full record, as it builds
Funding rounds
No funding rounds for Absology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Absology
Developer of in-vitro diagnostic systems designed to help save lives. The company offers various diagnostic kits, such as testosterone, vitamin D, PSA, TSH, FreeT4, and PCT, and also helps in anti-cancer therapy monitoring, cardiovascular disease, and Alzheimer's disease monitoring, enabling doctors to diagnose different types of medical conditions and treat them suitably.
- Sector
- Healthcare
- HQ
- Anyang, South Korea
- Founded
- 2017
- Employees
- 18
- Website
- absology.co.kr/
- Ownership
- Privately Held (backing)
Absology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Absology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Absology in its N-PORT filings yet. We sweep new filings monthly.